wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52641875-92291E7E-5D36-4007-8CF0-5CDA75A83631
Q52641875-92291E7E-5D36-4007-8CF0-5CDA75A83631
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52641875-92291E7E-5D36-4007-8CF0-5CDA75A83631
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.
P2860
Q52641875-92291E7E-5D36-4007-8CF0-5CDA75A83631
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52641875-92291E7E-5D36-4007-8CF0-5CDA75A83631
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b1c8168405f1c4d3937ab4f19fc70fd442a5761e
P2860
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.